ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,625.48
0.21%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. enGene Holdings Inc (ENGN)

  7. enGene Holdings Inc (ENGN) News

enGene (ENGN)

enGene Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ENGN
DateTimeSourceHeadlineSymbolCompany
29/05/202412:30Business WireenGene to Present at the Jefferies Global Healthcare ConferenceNASDAQ:ENGNenGene Holdings Inc
15/05/202421:05Business WireenGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of DirectorsNASDAQ:ENGNenGene Holdings Inc
02/05/202421:05PR Newswire (US)enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual MeetingNASDAQ:ENGNenGene Holdings Inc
02/05/202421:05PR Newswire (Canada)enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual MeetingNASDAQ:ENGNenGene Holdings Inc
09/04/202413:56PR Newswire (US)/C O R R E C T I O N -- enGene Inc./NASDAQ:ENGNenGene Holdings Inc
09/04/202413:00PR Newswire (US)engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical DevelopmentNASDAQ:ENGNenGene Holdings Inc
09/04/202413:00PR Newswire (Canada)engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical DevelopmentNASDAQ:ENGNenGene Holdings Inc
11/03/202421:16PR Newswire (Canada)enGene Reports First Quarter 2024 Financial Results and Recent Corporate ProgressNASDAQ:ENGNenGene Holdings Inc
11/03/202421:16PR Newswire (US)enGene Reports First Quarter 2024 Financial Results and Recent Corporate ProgressNASDAQ:ENGNenGene Holdings Inc
05/03/202412:00PR Newswire (US)enGene To Present at the Leerink Partners Global Biopharma ConferenceNASDAQ:ENGNenGene Holdings Inc
05/03/202412:00PR Newswire (Canada)enGene To Present at the Leerink Partners Global Biopharma ConferenceNASDAQ:ENGNenGene Holdings Inc
14/02/202411:50PR Newswire (Canada)enGene Announces Oversubscribed $200 Million Private Placement FinancingNASDAQ:ENGNenGene Holdings Inc
14/02/202411:50PR Newswire (US)enGene Announces Oversubscribed $200 Million Private Placement FinancingNASDAQ:ENGNenGene Holdings Inc
14/02/202411:45PR Newswire (Canada)enGene Announces Leadership Succession PlanNASDAQ:ENGNenGene Holdings Inc
14/02/202411:45PR Newswire (US)enGene Announces Leadership Succession PlanNASDAQ:ENGNenGene Holdings Inc
30/01/202412:00PR Newswire (Canada)enGene Appoints Lee Giguere as Chief Legal Officer and Corporate SecretaryNASDAQ:ENGNenGene Holdings Inc
30/01/202412:00PR Newswire (US)enGene Appoints Lee Giguere as Chief Legal Officer and Corporate SecretaryNASDAQ:ENGNenGene Holdings Inc
29/01/202412:00PR Newswire (Canada)enGene Reports Full Year 2023 Financial Results and Recent Operational ProgressNASDAQ:ENGNenGene Holdings Inc
29/01/202412:00PR Newswire (US)enGene Reports Full Year 2023 Financial Results and Recent Operational ProgressNASDAQ:ENGNenGene Holdings Inc
22/12/202322:00PR Newswire (Canada)enGene Announces Expanded $50 Million Debt Facility with Hercules CapitalNASDAQ:ENGNenGene Holdings Inc
22/12/202322:00PR Newswire (US)enGene Announces Expanded $50 Million Debt Facility with Hercules CapitalNASDAQ:ENGNenGene Holdings Inc
19/12/202312:00PR Newswire (US)enGene Appoints Lota S. Zoth, CPA, as Member of the Board of DirectorsNASDAQ:ENGNenGene Holdings Inc
19/12/202312:00PR Newswire (Canada)enGene Appoints Lota S. Zoth, CPA, as Member of the Board of DirectorsNASDAQ:ENGNenGene Holdings Inc
29/11/202312:00PR Newswire (Canada)enGene Appoints Ryan Daws as Chief Financial OfficerNASDAQ:ENGNenGene Holdings Inc
29/11/202312:00PR Newswire (US)enGene Appoints Ryan Daws as Chief Financial OfficerNASDAQ:ENGNenGene Holdings Inc
16/02/201211:30Dow Jones NewsBlackRock Set To Slice Corporate Bond ETFs By SectorNASDAQ:ENGNiShares Industrials Sector Bond Fund
 Showing the most relevant articles for your search:NASDAQ:ENGN

Your Recent History

LSE
BIRD
Blackbird
LSE
ITV
Itv
LSE
GOLD
LSE
POS
Plexus
LSE
TERN
Tern
LSE
SCLP
Scancell
LSE
GKP
Gulf Keystone Petroleum
LSE
AAZ
Anglo Asian Mining
LSE
KRS
Keras Resources
LSE
NG.
National Grid
LSE
BLOE
Block Energy
LSE
SAR
Sareum
LSE
CNR
Condor Gold
LSE
INSG
Insig Ai
LSE
PPP
Pennpetro Energy
LSE
RKH
Rockhopper Exploration
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved